Abortion Access Could Be Limited Further By Mifepristone Case
Mifepristone (Mifeprex) and Misoprostol, the two drugs used in a medication abortion, are seen at the Women's Reproductive Clinic, which provides legal medication abortion services, in Santa Teresa, New Mexico, on June 17, 2022. ROBYN BECK/AFP via Getty Images hide caption
Mifepristone (Mifeprex) and Misoprostol, the two drugs used in a medication abortion, are seen at the Women's Reproductive Clinic, which provides legal medication abortion services, in Santa Teresa, New Mexico, on June 17, 2022.
ROBYN BECK/AFP via Getty Images Was the FDA wrong to approve a drug that's used in nearly all medication abortions in the U.S. — and should the drug, mifepristone, be taken off the market? Those questions were argued in court Wednesday, in a case heard by federal Judge Matthew Kacsmaryk, a Trump appointee, in Amarillo, Texas.
The podcast is produced by Elena Moore and Casey Morell. It is edited by Eric McDaniel. Our executive producer is Muthoni Muturi. Research and fact-checking by Devin Speak.
Unlock access to this and other bonus content by supporting The NPR Politics Podcast+. Sign up via Apple Podcasts or at plus.npr.org.
Giveaway: npr.org/politicsplusgiveaway
Connect:
Email the show at nprpolitics@npr.org
Join the NPR Politics Podcast Facebook Group.
Subscribe to the NPR Politics Newsletter.